全文获取类型
收费全文 | 27413篇 |
免费 | 2475篇 |
国内免费 | 68篇 |
专业分类
耳鼻咽喉 | 290篇 |
儿科学 | 585篇 |
妇产科学 | 375篇 |
基础医学 | 3357篇 |
口腔科学 | 835篇 |
临床医学 | 3489篇 |
内科学 | 5881篇 |
皮肤病学 | 653篇 |
神经病学 | 2135篇 |
特种医学 | 1037篇 |
外科学 | 4016篇 |
综合类 | 468篇 |
一般理论 | 25篇 |
预防医学 | 2836篇 |
眼科学 | 414篇 |
药学 | 2141篇 |
中国医学 | 24篇 |
肿瘤学 | 1395篇 |
出版年
2022年 | 195篇 |
2021年 | 512篇 |
2020年 | 258篇 |
2019年 | 451篇 |
2018年 | 522篇 |
2017年 | 353篇 |
2016年 | 410篇 |
2015年 | 474篇 |
2014年 | 639篇 |
2013年 | 969篇 |
2012年 | 1370篇 |
2011年 | 1406篇 |
2010年 | 731篇 |
2009年 | 661篇 |
2008年 | 1191篇 |
2007年 | 1192篇 |
2006年 | 1216篇 |
2005年 | 1195篇 |
2004年 | 1119篇 |
2003年 | 1021篇 |
2002年 | 1029篇 |
2001年 | 981篇 |
2000年 | 1002篇 |
1999年 | 851篇 |
1998年 | 305篇 |
1997年 | 255篇 |
1996年 | 237篇 |
1995年 | 249篇 |
1994年 | 203篇 |
1993年 | 206篇 |
1992年 | 609篇 |
1991年 | 629篇 |
1990年 | 587篇 |
1989年 | 515篇 |
1988年 | 484篇 |
1987年 | 478篇 |
1986年 | 476篇 |
1985年 | 471篇 |
1984年 | 341篇 |
1983年 | 296篇 |
1982年 | 219篇 |
1981年 | 207篇 |
1979年 | 327篇 |
1978年 | 242篇 |
1977年 | 202篇 |
1974年 | 218篇 |
1973年 | 207篇 |
1972年 | 170篇 |
1971年 | 192篇 |
1970年 | 172篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
Vanaporn Wuthiekanun Varunee Desakorn Gumphol Wongsuvan Premjit Amornchai Allen C. Cheng Bina Maharjan Direk Limmathurotsakul Wirongrong Chierakul Nicholas J. White Nicholas P. J. Day Sharon J. Peacock 《Clinical and Vaccine Immunology : CVI》2005,12(4):555-556
An immunofluorescent (IF) method that detects Burkholderia pseudomallei in clinical specimens within 10 min was devised. The results of this rapid method and those of an existing IF method were prospectively compared with the culture results for 776 specimens from patients with suspected melioidosis. The sensitivities of both IF tests were 66%, and the specificities were 99.5 and 99.4%, respectively. 相似文献
22.
Patient-controlled analgesia. Does a concurrent opioid infusion improve pain management after surgery? 总被引:4,自引:0,他引:4
OBJECTIVE.--To assess the influence of a continuous (basal) morphine infusion as part of a patient-controlled analgesia (PCA) system on the postoperative analgesic requirement and on recovery parameters following abdominal hysterectomy. DESIGN.--Single-center, randomized, controlled protocol. SETTING.--University medical center. PARTICIPANTS.--A total of 230 adult women were randomly assigned to receive no morphine infusion (control group) or a continuous 0.5-, 1.0-, or 2.0-mg/h morphine infusion. Each patient was able to self-administer supplemental intravenous bolus doses of morphine (1 to 2 mg) using a PCA infuser. MAIN OUTCOME MEASURES.--Use of the PCA device, opioid-related side effects, recovery times, and the patients' assessment of pain and sedation on linear visual analog scales were recorded during the 72-hour study period. Follow-up questionnaires were completed by the patients and their health care professionals to assess the overall adequacy of PCA therapy. RESULTS.--Patients who received the 2-mg/h morphine infusions received significantly more opioid medication 9 to 72 hours after their operation than those who received no infusion (control group). The presence of a continuous morphine infusion of 0.5 to 2 mg/h did not significantly decrease the number of patient demands or supplemental bolus doses administered compared with the control group. Overall, 168 (84%) of the 199 patients who completed the 72-hour study were able to achieve adequate analgesia without requiring changes in the PCA regimen or experiencing major side effects. Recovery times and outcome variables were similar in all four groups. CONCLUSION.--The routine use of a continuous opioid infusion in combination with a standard PCA regimen does not improve pain management compared with PCA alone after abdominal hysterectomy. 相似文献
23.
Cardiac imaging in the evaluation of patients presenting to the emergency department with chest pain
Conclusions Despite the utility and benefits that each imaging modality has to offer, it is easy to see why there is still no perfect
choice for a noninvasive cardiac imaging modality to assist in the management of chest pain patients. All of the current imaging
techniques have their own significant strengths and weaknesses when compared with other modalities. SPECT and echocardiography
are wellestablished technologies that can directly assess the presence of myocardial ischemia and its functional consequence
on RF; newer and more expensive techniques such as MDCT and CMR can directly assess coronary anatomy and have just started
to be evaluated in the acute chest pain setting. There are no studies that directly compare these technologies, and more data
are clearly needed before the question of whether anatomic imaging versus perfusion/function imaging is the better approach
can be answered. Other comparisons such as relative safety, availability, logistics, and cost-effectiveness between the various
technologies are also lacking.
Of all of the imaging modalities discussed, MCE is the only portable technology. The images do not require expensive software
or other technology for offline processing before interpretation, and any trained cardiologist can read the study at the bedside
or, potentially, over the Internet, providing near-instantaneous results in the acute cardiac setting, where time is of the
essence.
MCE is also relatively cheap compared with other technologies, a potential advantage for payors but not necessarily for payees.
How reimbursement rates and fee structures eventually affect clinical practice is also unknown.
Despite these and other questions that need to be answered before any one technique will be used exclusively, the future of
noninvasive cardiac imaging remains an exciting and ever-changing field. The adaptation of any one of these techniques into
its proper role in the ED Journal of Nuclear Cardiology Wyrick and Wei 753 Volume 13, Number 6;749-55 Cardiac imaging in patients
with chest pain will take considerably more time and effort in terms of research, money, and time-tested clinical experience. 相似文献
24.
25.
Pawan Kumar Dhruva Rao Deborah Clements Michael M. Davies Jared Torkington 《Surgical endoscopy》2007,21(6):1036
We present our comments on the above article. 相似文献
26.
G C Palmer M L Stagnitto J M Ordy R C Griffith J J Napier R J Gentile J H Woodhead H S White E A Swinyard 《Epilepsy research》1991,8(1):36-48
Stereoisomers of remacemide (racemate form) were compared for anticonvulsant efficacy and safety in mice. In the maximal electroshock seizure (MES) test for oral efficacy, the (-) stereoisomer, FPL 14145, was more potent than the racemate or the (+) stereoisomer, FPL 14144. Respective ED50 values (expressed as mg/kg) were: remacemide, 58; FPL 14145, 45; FPL 14144, 79. In 2 of 3 tests for neural impairment, FPL 14145 yielded significantly better therapeutic indices (toxic dose 50/ED50) than the racemate. The margin of safety (estimated median lethal dose ED50) was more favorable for FPL 14144: remacemide, 15.1; FPL 14144, 18.9; FPL 14145, 15.7. The duration of protection against MES indicated the stereoisomers were longer acting than the racemate. After intravenous administration the order of potency against MES was similar: FPL 14145 greater than remacemide greater than FPL 14144. Following daily administration of the oral ED98 for 4 days, with a dose response curve run on day 5, the MES ED50 values for all compounds were increased. The test indicates tolerance. In the pentylenetetrazol infusion test the racemate and FPL 14144 demonstrated more proconvulsant properties than FPL 14145. Intraperitoneal administration of 50 mg/kg or more produced changes in behavior with all compounds. At higher doses the racemate and FPL 14145 elicited more severe symptoms with death at 200 mg/kg. 相似文献
27.
28.
Between 1969 and 1993, 123 patients were accepted in this unit for surgery for refractory hyperparathyroidism associated with chronic renal failure. Subtotal parathyroidectomy was the procedure of choice. At operation, four or more parathyroids were identified in 75% of patients. Methylene blue localised additional parathyroids in 32% of initial explorations in which it was used. Coincidental thyroid pathology was found in 8.3%, including papillary carcinoma in 2.4%. No further parathyroid surgery was required in 90% of patients at a mean of 6.6 years after operation. Reoperation (10%) was more likely to be required (14.3%) when less than four glands were found than when four or more were found (8.5%). Patients continuing on dialysis were more likely to need reoperation than those with functioning renal transplants. 相似文献
29.
Gel filtration chromatography and SDS-PAGE of venom from two specimens of Demansia psammophis showed little similarity. Amidolytic activity of the venoms, however, was in the same order of reactivity against various chromogenic substrates. The venom from both snakes produced precipitin lines with brown snake antivenom but the venom detection kit (Commonwealth Serum Laboratories) identified one venom as brown snake (Pseudonaja sp.) and the other as tiger snake (Notechis sp.). These results raise questions about the phylogeny of this species. 相似文献
30.
Effect of ciprofibrate, bezafibrate, and LY171883 on peroxisomal beta-oxidation in cultured rat, dog, and rhesus monkey hepatocytes 总被引:3,自引:0,他引:3
P S Foxworthy S L White D M Hoover P I Eacho 《Toxicology and applied pharmacology》1990,104(3):386-394
Cultured rat hepatocytes have been used extensively to study the mechanisms of chemically induced peroxisome proliferation. Hepatocytes from nonrodent species have been used on a limited scale to study interspecies differences in the response. Because of their importance in pharmaceutical safety assessment, we have developed a model to study the response of beagle dog and rhesus monkey hepatocytes to peroxisome proliferators. Treatment of the hepatocytes with peroxisome proliferators was begun after 20 hr in culture and continued for 72 hr. Untreated rat, dog, and monkey hepatocytes retained 62, 42, and 43% of their initial (20 hr) peroxisomal beta-oxidation activity throughout 92 hr of culture. Ciprofibrate, bezafibrate, and LY171883 caused a dose-related increase in beta-oxidation in rat hepatocytes to a maximum of 10-, 8-, and 5-fold, respectively. In dog and monkey hepatocytes the increases in beta-oxidation were less than 2-fold. Peroxisome morphology in dog and monkey hepatocytes appeared to be unchanged by the drugs. Morphometric analysis in monkey hepatocytes showed no increase in peroxisome volume fraction in response to the chemicals. Treatment of dog and monkey hepatocytes with dexamethasone and glucagon during the final 24 hr in culture caused a 4- to 6-fold increase in tyrosine aminotransferase activity. This induction is characteristic of the in vivo response. The small increase in beta-oxidation reflects the relative insensitivity of the dog and monkey liver to peroxisome proliferators in vivo rather than a loss of sensitivity during culture. Cultured hepatocytes from beagle dog and rhesus monkey may provide a model for studying the mechanisms underlying the interspecies differences. Such information would help clarify the relevance of rodent data in human risk assessment. 相似文献